Human immunodeficiency virus postexposure prophylaxis for occupational exposure in a medical school hospital in Thailand

Journal of Hospital Infection

Volumn 67, Issue 4, 2007, Pages 344-349

  Hiransuthikul, N ^a   Hiransuthikul, P ^a   Kanasuk, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Antiretroviral drug; HIV; Occupational exposure; Postexposure prophylaxis; Thailand

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DATA COLLECTION METHOD; DIARRHEA; DIZZINESS; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY WARD; FACE EDEMA; FATIGUE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENT REPORT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; NAUSEA; NURSE; OCCUPATIONAL ACCIDENT; OCCUPATIONAL EXPOSURE; PATIENT COUNSELING; RISK ASSESSMENT; SKIN INJURY; THAILAND; VOMITING; WARD;

ADULT; ALLIED HEALTH PERSONNEL; ANTI-RETROVIRAL AGENTS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; FEMALE; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NEEDLESTICK INJURIES; NURSES; OCCUPATIONAL EXPOSURE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; THAILAND; TREATMENT OUTCOME;

EID: 36448949758     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.09.014     Document Type: Article

References (21)

1. Pungpapong S., Phanuphak P., Pungpapong K., and Ruxrungtham K. The risk of occupational HIV exposure among Thai healthcare workers. Southeast Asian J Trop Med Public Health 30 (1999) 496-503
2. CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 50 RR-11 (2001) 1-52
3. Young T.N., Arens F.J., Kennedy G.E., Laurie J.W., and Rutherford G. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev 1 (2007) CD002835
4. Gerberding J.L. Clinical practice. Occupational exposure to HIV in health care settings. N Engl J Med 348 (2003) 826-833
5. Beltrami E.M., Williams I.T., Shapiro C.N., and Chamberland M.E. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev 13 (2000) 385-407
6. Panlilio A.L., Cardo D.M., Grohskopf L.A., Heneine W., and Ross C.S. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 54 RR-9 (2005) 1-17
7. Hiransuthikul N., Tantithippong A., and Jiamjarasrangsri W. Occupational exposures among nurses and housekeeping personnel in King Chulalongkorn Memorial Hospital. J Med Assoc Thai 89 Suppl. 3 (2006) S140-S150
8. Ippolito G., Puro V., Heptonstall J., Jagger J., De Carli G., and Petrosillo N. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 28 (1999) 365-383
9. Tarantola A., Golliot F., Astagneau P., Fleury L., Brucker G., and Bouvet E. Occupational blood and body fluids exposures in health care workers: four-year surveillance from the Northern France network. Am J Infect Control 31 (2003) 357-363
10. Rapparini C. Occupational HIV infection among health care workers exposed to blood and body fluids in Brazil. Am J Infect Control 34 (2006) 237-240
11. Bi P., Tully P.J., Pearce S., and Hiller J.E. Occupational blood and body fluid exposure in an Australian teaching hospital. Epidemiol Infect 134 (2006) 465-471
12. Oh H.S., Yi S.E., and Choe K.W. Epidemiological characteristics of occupational blood exposures of healthcare workers in a university hospital in South Korea for 10 years. J Hosp Infect 60 (2005) 269-275
13. CDC. Recommendations for prevention of HIV transmission in health-care settings. MMWR Morb Mortal Wkly Rep 36 Suppl. 2 (1987) 1S-18S
14. Tsai C.C., Emau P., Sun J.C., et al. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. J Med Primatol 29 (2000) 248-258
15. Bottiger D., Johansson N.G., Samuelsson B., et al. Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005. AIDS 11 (1997) 157-162
16. Shapiro D.E., Sperling R.S., and Coombs R.W. Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. Pediatric AIDS Clinical Trials Group 076 Study Group. Lancet 354 (1999) 156 [author reply 157-158]
17. Sperling R.S., Shapiro D.E., Coombs R.W., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 335 (1996) 1621-1629
18. Connor E.M., Sperling R.S., Gelber R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331 (1994) 1173-1180
19. Cardo D.M., Culver D.H., Ciesielski C.A., et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 337 (1997) 1485-1490
20. Chersich M.F., Urban M.F., Venter F.W., et al. Efavirenz use during pregnancy and for women of child-bearing potential. AIDS Res Ther 3 (2006) 11
21. Tsai C.C., Emau P., Follis K.E., et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 72 (1998) 4265-4273